Archive for October, 2008

Rising Diabetes cost in the US

Submitted by THE HEALTH ECONOMICS BLOG
From The Wall Street Journal
CHICAGO — Americans with diabetes nearly doubled their spending on drugs for the disease in just six years, with the bill last year climbing to $12.5 billion.
Newer, more costly drugs are driving the increase, said researchers, despite a lack of strong evidence for the new drugs’ [...]

UK cancer patients threaten to sue NHS for drug cost refunds

Submitted by THE HEALTH ECONOMICS BLOG

Patients ‘demand refunds for expensive cancer drugs’ on the NHS
Patients denied expensive cancer drugs on the NHS are threatening to sue their local healthcare trusts for refunds.
By Kate Devlin, Medical Correspondent
Last Updated: 3:28AM GMT 28 Oct 2008
from The Telegraph
Hundreds of patients have been told that the life extending medications are [...]

The Pharmaevolution

Submitted by THE HEALTH ECONOMICS BLOG

It is a challenging time for the pharmaceutical industry, with recent announcements of more job cuts at GSK R&D and the latest news of Pfizer abandoning research on key areas of the past, such as cardiovascular, bone health and obesity. In addition, strategic actions are now being taken in order [...]

Health Economics Opportunities in North America

Submitted by THE HEALTH ECONOMICS BLOG
All,
please see below a few new jobs on offer in the US and Canada. Please contact Darren Kruszynski.
Global Project Leader Oncology HE/Outcomes/Reimbursement - 130+ New Jersey
Deputy Director, US Health Economics, Outcomes & Reimbursement (HEOR), Women’s Healthcare - 150+ New Jersey
Associate Director, Medical Outcomes Research - 150+ Connecticut
Health Economics Manager - [...]

UK is negotiating with drugmakers to lower NHS prices

Submitted by THE HEALTH ECONOMICS BLOG
by Anna Bratulic
The UK government is negotiating with pharmaceutical companies to offer lower prices for new drugs on the understanding that the NHS will pay more for the treatments if “later evidence proves greater effectiveness.” Government officials see the move as “an answer to whether patients should be allowed to [...]

New Vacancies Health Economics & Pricing

Submitted by THE HEALTH ECONOMICS BLOG
Hi everyone,
all positions below just came in. Please get in touch with Simon Rose.
Cheers
Ulf
- Health Economy Liaison Manager – Field Based, Multiple locations – UK
- Health Economist, Berks – UK
- Senior Health Economist, Home Counties – UK
- Senior Contracts & Pricing Manager, Switzerland
- Senior Project Manager International Health Economics, Switzerland
- [...]

New HTA and Pricing events organized by Health Network Communications

Submitted by THE HEALTH ECONOMICS BLOG
Health Technology Assessment World Europe 2008
Health Network Communications, in association with the London School of Economics is organising the first annual policy forum for the industry where all the major international HTA agencies and leading pharmaceutical companies will be able to discuss the challenges in obtaining market access. Health Technology [...]